115 related articles for article (PubMed ID: 28685937)
21. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
22. Neuroinflammatory processes in Parkinson's disease.
Hirsch EC; Hunot S; Hartmann A
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S9-S15. PubMed ID: 15885630
[TBL] [Abstract][Full Text] [Related]
23. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
[TBL] [Abstract][Full Text] [Related]
24. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M
Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195
[TBL] [Abstract][Full Text] [Related]
25. Differential Neuronal Plasticity of Dental Pulp Stem Cells From Exfoliated Deciduous and Permanent Teeth Towards Dopaminergic Neurons.
Majumdar D; Kanafi M; Bhonde R; Gupta P; Datta I
J Cell Physiol; 2016 Sep; 231(9):2048-63. PubMed ID: 26773559
[TBL] [Abstract][Full Text] [Related]
26. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
[TBL] [Abstract][Full Text] [Related]
27. Lipid-like components released from degenerating dopaminergic neurons trigger the dynamic migration of microglia.
Kim H; Park JH; Kim K
Biochem Biophys Res Commun; 2012 Sep; 426(1):18-25. PubMed ID: 22898047
[TBL] [Abstract][Full Text] [Related]
28. Ultrafine carbon particles promote rotenone-induced dopamine neuronal loss through activating microglial NADPH oxidase.
Wang Y; Liu D; Zhang H; Wang Y; Wei L; Liu Y; Liao J; Gao HM; Zhou H
Toxicol Appl Pharmacol; 2017 May; 322():51-59. PubMed ID: 28283350
[TBL] [Abstract][Full Text] [Related]
29. Neurogenic differentiation of dental pulp stem cells to neuron-like cells in dopaminergic and motor neuronal inductive media.
Chang CC; Chang KC; Tsai SJ; Chang HH; Lin CP
J Formos Med Assoc; 2014 Dec; 113(12):956-65. PubMed ID: 25438878
[TBL] [Abstract][Full Text] [Related]
30. Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism.
Annese V; Herrero MT; Di Pentima M; Gomez A; Lombardi L; Ros CM; De Pablos V; Fernandez-Villalba E; De Stefano ME
Brain Struct Funct; 2015 Mar; 220(2):703-27. PubMed ID: 24558048
[TBL] [Abstract][Full Text] [Related]
31. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
[TBL] [Abstract][Full Text] [Related]
32. Damage to dopaminergic neurons is mediated by proliferating cell nuclear antigen through the p53 pathway under conditions of oxidative stress in a cell model of Parkinson's disease.
Li DW; Li GR; Zhang BL; Feng JJ; Zhao H
Int J Mol Med; 2016 Feb; 37(2):429-35. PubMed ID: 26677001
[TBL] [Abstract][Full Text] [Related]
33. A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C).
Smith GA; Rocha EM; Rooney T; Barneoud P; McLean JR; Beagan J; Osborn T; Coimbra M; Luo Y; Hallett PJ; Isacson O
PLoS One; 2015; 10(3):e0121072. PubMed ID: 25815475
[TBL] [Abstract][Full Text] [Related]
34. Cytosolic phospholipase A2 plays a crucial role in ROS/NO signaling during microglial activation through the lipoxygenase pathway.
Chuang DY; Simonyi A; Kotzbauer PT; Gu Z; Sun GY
J Neuroinflammation; 2015 Oct; 12():199. PubMed ID: 26520095
[TBL] [Abstract][Full Text] [Related]
35. Neuroinflammation and cell therapy for Parkinson's disease.
Li F; Zhu S; Wu C; Yan C; Liu Y; Shugan L
Front Biosci (Schol Ed); 2011 Jun; 3(4):1407-20. PubMed ID: 21622277
[TBL] [Abstract][Full Text] [Related]
36. Human amniotic fluid stem cells do not differentiate into dopamine neurons in vitro or after transplantation in vivo.
Donaldson AE; Cai J; Yang M; Iacovitti L
Stem Cells Dev; 2009 Sep; 18(7):1003-12. PubMed ID: 19049321
[TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity.
McLaughlin P; Zhou Y; Ma T; Liu J; Zhang W; Hong JS; Kovacs M; Zhang J
Glia; 2006 Apr; 53(6):567-82. PubMed ID: 16419087
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of stem cells derived from carious teeth into dopaminergic-like cells.
Gnanasegaran N; Govindasamy V; Abu Kasim NH
Int Endod J; 2016 Oct; 49(10):937-49. PubMed ID: 26354006
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures.
Zhu Y; Chen X; Liu Z; Peng YP; Qiu YH
Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26729090
[TBL] [Abstract][Full Text] [Related]
40. Transduced PEP-1-PON1 proteins regulate microglial activation and dopaminergic neuronal death in a Parkinson's disease model.
Kim MJ; Park M; Kim DW; Shin MJ; Son O; Jo HS; Yeo HJ; Cho SB; Park JH; Lee CH; Kim DS; Kwon OS; Kim J; Han KH; Park J; Eum WS; Choi SY
Biomaterials; 2015 Sep; 64():45-56. PubMed ID: 26117230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
